GLYCO, unfortunately the ASX is not the NASDAQ, company valuations are very conservative here in Oz compared to overseas markets. However, I do agree with your sentiment that IAM is an awesome LT Growth story.
The Dec Qtr report needs to reflect some improved earnings, those numbers alone will sustain SP growth along with confirmation on the Sentry deal and MOU2 or MOU3 in the Dec - March qtr. Qtr end reports are now going to be vital to the IAM business as we move away from the speculative end of town.
What conservative valuation can someone place on this company? I don't believe that its currently possible and that's what attracts me to this company, cheers
Ann: Intiger Commences Pilot and Partnership Program, page-949
-
- There are more pages in this discussion • 1,276 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CF1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $11.92M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.1¢ | $9.754K | 464.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 235662 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 220000 | 1 |
View Market Depth
| Last trade - 14.46pm 16/08/2024 (20 minute delay) ? |
| CF1 (ASX) Chart |